Achieving diversity in clinical trials is crucial for developing effective and safe treatments for all populations. Yet, financial barriers often exclude underrepresented groups from participating, hindering progress towards health equity. This disparity raises critical questions about the accessibility and inclusivity of medical research.
In this insightful Q&A, Meghan Harrington, VP of Clinical Trial Financial Management at Medidata, a Dassault Systèmes brand, sheds light on the
Read More
Decentralized Clinical Trials
How A Human-AI Partnership Can Boost Clinical Trial Recruitment
The demand for clinical trial testing is rising, from over 260,000 trials conducted in 2018 to nearly double that figure in 2024. This means that more trials are being conducted simultaneously than ever—a factor that adds to the already challenging process of finding clinical trial participants.
Because trial sponsors are struggling to find sufficient numbers of suitable participants, 80% of the world’s more than 450,000 clinical trials are at risk of
Read More
IRT: The Unsung Hero of Modern Clinical Trials
The modern landscape of clinical trials is expanding to include hybrid and decentralized approaches to conducting research. As the methods of conducting clinical trials diversify, clinical trial logistics also increase in complexity. In 2024, experts estimate that 50% of clinical trials will be conducted via hybrid or decentralized methods. Though increasing remote access in clinical trials improves convenience, reduces costs and expands diversity, it also presents new challenges in navigating
Read More
Power Secures $11.9M to Democratize Clinical Trials
What You Should Know:
- Power, the company transforming the traditional clinical trial landscape, announced today the close of their $11.9M Series A funding round led by Kin, Contrary, and Footwork.
- The strategic funding fuels Power's mission to democratize access to clinical trials and diversify the pool of participants, ultimately accelerating life-saving medical research.
Revolutionizing Clinical Trial Participation
Founded in 2021 by Brandon Li and Michael Gill, Power
Read More
VR Mask for PTSD Shows Promise in Decentralized Trial, Aims for FDA Breakthrough Designation
What You Should Know:
- Curavit Clinical Research, a leader in decentralized clinical trials (DCTs) for digital therapeutics (DTx), successfully completed a study for the Sana Device, a virtual reality (VR) mask aiming to reduce post-traumatic stress disorder (PTSD) symptoms.
- Overall, this study represents a significant step forward in the development of VR-based treatments for PTSD. If approved, the Sana Device could offer a valuable tool for patients struggling with this
Read More
H1 Unveils GenosAI Pro: Supercharging Clinical Trials with Conversational AI
What You Should Know:
- H1, the go-to resource for healthcare professionals, clinical trial information, and life sciences research, announced the launch of its conversational AI tool GenosAI Pro.
- The conversational AI tool empowers pharmaceutical companies to streamline workflows, enhance data-driven decision-making, and optimize clinical trial processes within the Trial Landscape platform.
Transforming Clinical Trial Design
Building upon the success of GenosAI Lite, GenosAI Pro
Read More
Labcorp & Hawthorne Effect Partner to Supercharge Decentralized Clinical Trials
What You Should Know:
- Labcorp, a global leader in innovative laboratory services, and Hawthorne Effect, Inc., a pioneer in technology-driven clinical trial solutions, have announced a groundbreaking partnership to revolutionize clinical trials with a focus on decentralization.
- This collaboration aims to unlock unprecedented levels of patient diversity, reduce site burden, and accelerate study timelines for pharmaceutical, biotech, and medical device sponsors.
Decentralization: The
Read More
Q/A: AiCure SVP Talks How Digital Health Can Improve Access to Clinical Trials
The imperative to enhance access to quality care and research is a central concern gripping both the healthcare and pharmaceutical sectors. At the heart of this challenge lies the crucial necessity for clean and streamlined patient data, which currently suffers from inadequacies in comprehensiveness and accuracy. Addressing this pivotal issue carries immense benefits, particularly in the sphere of targeted trial recruitment efforts. By harnessing better patient data records, the possibilities
Read More
How to Achieve Health Equity in Decentralized Clinical Trials
Trial sponsors have made efforts to address underrepresentation and promote Diversity, Equity and Inclusion (DEI) in clinical trials since the Federal and Drug Administration’s (FDA) 2016 guidance, but a new report released by the Government Accountability Office (GAO) still shows a continuous presence of major gaps in patient diversity. It begs the question: how do we ultimately achieve full representation and ensure accountability to uphold the promises we have made for
Read More
Walgreens and Freenome Partner to Increase Diversity in Research
What You Should Know:
Walgreens and Freenome form a multi-year relationship to advance clinical studies of Freenome’s blood-based tests for the early detection of cancer. Walgreens will combine its national footprint, patient insights, compliant recruitment technology and local infrastructure to engage diverse patient populations in Freenome’s multi-cancer research program. Walgreens will initially recruit patients across diverse populations for Freenome’s Sanderson Study, which aims to
Read More
